Sandoz shares plunged Wednesday on their market debut after the generic and biosimilar drugmaker’s worth was measured at a lower-than-expected 10.3 billion Swiss francs ($11.2…
Sandoz shares plunged Wednesday on their market debut after the generic and biosimilar drugmaker’s worth was measured at a lower-than-expected 10.3 billion Swiss francs ($11.2…